Patients with ≥ 20 × 10(9)/l platelets at baseline may have a prompt response to romiplostim during the early phase of treatment: an italian single-institution experience.
Mediterr J Hematol Infect Dis
; 4(1): e2012044, 2012.
Article
en En
| MEDLINE
| ID: mdl-22811793
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
Mediterr J Hematol Infect Dis
Año:
2012
Tipo del documento:
Article
País de afiliación:
Italia